Author： Suker Janet Feavers Ian M
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.2, Iss.3, 2001-08, pp. : 273-283
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Australian meningococcal vaccination programme expanded
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 393, 2002-01 ,pp. :
Access to resources
Recommend
Economic evaluations valuable in meningococcal vaccination
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 488, 2005-01 ,pp. :
Meningococcal Vaccination: Cui Bono?
PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. :
Infant meningococcal vaccination cost effective in Brazil
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :
Prospects for Vaccination in Prostate Cancer
By Perry M.J.A. Hrouda D. Dalgleish A.G.
Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. :